There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno